Business Trends

Jul 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
Jul 17, 2018
By BioPharm International Editors
Moderna’s new manufacturing plant in Norwood, MA gives the company capacity for preclinical and Phase I and II clinical manufacturing for its mRNA development candidates, including personalized cancer vaccines.
Jul 12, 2018
By BioPharm International Editors
CPhI Korea to feature zone for finished dosage formulation drug products.
Jul 11, 2018
By BioPharm International Editors
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
Jul 09, 2018
By BioPharm International Editors
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
Jul 01, 2018
BioPharm International
Biosimilars and biobetters face developmental challenges to achieving commercialization.
Jul 01, 2018
BioPharm International
Increasing demand for biologics is driving the need for innovation in bioprocessing.
Jul 01, 2018
BioPharm International
Biopharma companies can balance competing demands from patients, investors, and regulators by keeping a focus on science.
Jul 01, 2018
BioPharm International
After 30 years of biologic-drug advances, the industry and patients still have a lot to learn.
Jul 01, 2018
BioPharm International
This article highlights 15 years of changes in biopharmaceutical manufacturing.
native1_300x100
lorem ipsum